Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Price History  |  Ratios  |  Insiders

Stock Quote Today & Recent News Palisade Bio Inc PALI

Healthcare Biotechnology
Palisade Bio, Inc., a clinical-stage biopharmaceutical company, focuses on developing and advancing novel therapeutics for patients living with autoimmune, inflammatory, and fibrotic diseases. The company’s lead therapeutic candidate is PALI-2108, a prodrug PDE4 inhibitor that is in phase 1a/b clinical trial for the treatment of ulcerative colitis, as well as under phase 1a clinical trial for... see more

Current News (NDAQ:PALI)

Palisade Bio Announces Two Abstracts Selected for Poster Presentations at Leading Global Inflammatory Bowel Disease Conferences

GlobeNewswire 1 day ago

Palisade Bio Announces Strategic Equity Investment from the Crohn's & Colitis Foundation's IBD Ventures Program to Advance PALI-2108

GlobeNewswire 10 days ago

Palisade Bio Announces Granting of Japanese Patent Covering Composition of Matter for Lead Product Candidate, PALI-2108

GlobeNewswire December 30, 2025

Palisade Bio Strengthens Clinical Leadership Team with Appointment of James Izanec, MD, AGAF as Vice President, Clinical Development

GlobeNewswire December 2, 2025

Palisade Bio to Present at the Piper Sandler 37th Annual Healthcare Conference

GlobeNewswire November 25, 2025

Palisade Bio Appoints Sharon Skare as Vice President, Global Head of Clinical Operations

GlobeNewswire October 28, 2025

SHAREHOLDER ALERT: Purcell & Lefkowitz LLP Announces Shareholder Investigation of Palisade Bio, Inc. (NASDAQ: PALI)

PR Newswire October 20, 2025

Palisade Bio Announces First Patients Dosed in Phase 1b Study of Oral First-In-Class PDE4 Inhibitor Prodrug, PALI-2108, for the Treatment of Fibrostenotic Crohn's Disease (FSCD)

GlobeNewswire October 20, 2025

Palisade Bio Granted Canadian Patent Covering Composition of Lead Product Candidate PALI-2108 

GlobeNewswire October 13, 2025
View More News ››

Opinion & Analysis (NDAQ:PALI)

The Calandra Report: More biotech, Bitterroot, CTIX, BCRX, CUR and more

Thom Calandra January 14, 2014

The Calandra Report: Watch this hot tub!

Thom Calandra January 10, 2014
View More Opinion ››

Bullboard Posts (NDAQ:PALI)

Using technical analysis for this stock.

It is signalling a continuing uptrend for shareholders today anyway,so good luck to all
coolfooldumbguy - October 6, 2025

Buy buddy buy.

Otherwise FOMO for you fellas out there today anyway,so good luck to all of you guys
coolfooldumbguy - October 1, 2025

Pali ... No surprise here Folks. U've all been had Again !!

Palisade Bio Announces Exercise of Previously Issued Warrants for $3.9 Million 2025-07-23 17...
Iseneschal - July 23, 2025

PALI..... All I see is Volume increasing....Price Action meh

Maybe 1 day Cheers !
Iseneschal - June 10, 2025

PALI..... On watch

Sub 70 pesos now Pump is coming ; )
Iseneschal - June 6, 2025

PALI......NR this a.m with Vol & Price action

Big sell off during Regular hours til just before power hour LoL......MM shook everyone out  Ruthless LoL
Iseneschal - January 16, 2025
View more Bullboard ››

LaFleur Minerals Inc.

LaFleur Minerals Inc.

LaFleur Minerals Inc. explores for lithium and gold deposits in Canada. The company holds interest in the Swanson Gold ...
View More »

Podcasts